Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

Weiping Li(Mayo Clinic in Arizona), Mamta Gupta(George Washington University)
Journal of Hematology & Oncology
July 9, 2019
Cited by 108


Related Papers